SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 583.48 |
| Enterprise Value ($M) | 112.10 |
| Book Value ($M) | 486.93 |
| Book Value / Share | 9.05 |
| Price / Book | 1.20 |
| NCAV ($M) | 425.23 |
| NCAV / Share | 7.90 |
| Price / NCAV | 1.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.25 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.01 |
| Current Ratio | 10.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 485.41 |
| Assets | 547.11 |
| Liabilities | 60.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 135.16 |
| Operating Income | -154.56 |
| Net Income | -122.31 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -150.05 |
| Cash from Investing | -0.30 |
| Cash from Financing | 1.55 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Scully William P | 10.30 | 37.71 | |
| 13G/A | Fennell Todd W. | 8.60 | 46.59 | |
| 13G/A | Wellington Management Group Llp | 9.50 | 22.78 | |
| 13D/A | EcoR1 Capital, LLC | 21.50 | 0.00 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 7.10 | -9.91 | |
| 13G/A | State Street Corp | 3.10 | -39.28 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 174,820 | 654,495 | 26.71 | |
| 276,126 | 1,051,327 | 26.26 | |
| 90,079 | 347,728 | 25.91 | |
| 95,320 | 390,666 | 24.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMVP – PMV Pharmaceuticals, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated | PTCT – PTC Therapeutics, Inc. |
| PYXS – Pyxis Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io